NK cells in allogeneic bone marrow transplantation Ioannis A. Voutsadakis Review 26 June 2003 Pages: 525 - 534
Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer Richard P. CiavarraRoy R. BrownKenneth D. Somers Original Article 24 June 2003 Pages: 535 - 545
CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26 Kiyoshi ShinguAndreas HelfritzStephan von Hörsten Original Article 08 May 2003 Pages: 546 - 554
Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels Takusaburo EbinaNaoko OgamaNoriko Isono Original Article 17 June 2003 Pages: 555 - 560
Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use Hideo KurokiTakashi MorisakiMitsuo Katano Original Article 24 May 2003 Pages: 561 - 568
Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses Henderikus G. OttenGijsbert C. de GastMargreet Jonker Original Article 29 May 2003 Pages: 569 - 575
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck David R. ColnotJan C. RoosGuus A. M. S. van Dongen Original Article 03 June 2003 Pages: 576 - 582
